JP2010512169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512169A5 JP2010512169A5 JP2009541546A JP2009541546A JP2010512169A5 JP 2010512169 A5 JP2010512169 A5 JP 2010512169A5 JP 2009541546 A JP2009541546 A JP 2009541546A JP 2009541546 A JP2009541546 A JP 2009541546A JP 2010512169 A5 JP2010512169 A5 JP 2010512169A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- seq
- solvent
- nucleoside
- coupling solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86958806P | 2006-12-12 | 2006-12-12 | |
| US60/869,588 | 2006-12-12 | ||
| PCT/US2007/087183 WO2008073960A2 (en) | 2006-12-12 | 2007-12-12 | Oligonucleotides containing high concentrations of guanine monomers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512169A JP2010512169A (ja) | 2010-04-22 |
| JP2010512169A5 true JP2010512169A5 (enExample) | 2011-03-24 |
| JP5389662B2 JP5389662B2 (ja) | 2014-01-15 |
Family
ID=39456527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009541546A Active JP5389662B2 (ja) | 2006-12-12 | 2007-12-12 | 高濃度のグアニン・モノマーを含有するオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8586728B2 (enExample) |
| EP (1) | EP2125854B1 (enExample) |
| JP (1) | JP5389662B2 (enExample) |
| CN (1) | CN101611048B (enExample) |
| AU (1) | AU2007333147B2 (enExample) |
| CA (1) | CA2671873C (enExample) |
| WO (1) | WO2008073960A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008063490B4 (de) * | 2008-12-17 | 2023-06-15 | Merck Patent Gmbh | Organische Elektrolumineszenzvorrichtung und Verfahren zum Einstellen des Farbortes einer weiß emittierenden Elektrolumineszenzvorrichtung |
| WO2012059510A1 (en) | 2010-11-02 | 2012-05-10 | Girindus America, Inc. | Back pressure control during solid-phase synthesis on polymeric supports |
| US10040048B1 (en) | 2014-09-25 | 2018-08-07 | Synthego Corporation | Automated modular system and method for production of biopolymers |
| CA2972757A1 (en) | 2014-12-31 | 2016-07-07 | Arthur M. Krieg | Combination tumor immunotherapy |
| WO2017005818A1 (en) * | 2015-07-08 | 2017-01-12 | Kuros Biosciences Ag | Guanine-rich oligonucleotides |
| EP3436066A1 (en) | 2016-04-01 | 2019-02-06 | Checkmate Pharmaceuticals, Inc. | Fc receptor-mediated drug delivery |
| US20190076814A1 (en) | 2017-09-11 | 2019-03-14 | Synthego Corporation | Biopolymer synthesis system and method |
| WO2019080704A1 (zh) * | 2017-10-25 | 2019-05-02 | 深圳华大生命科学研究院 | 用于核酸合成的微流控芯片 |
| EP3752194A4 (en) | 2018-02-13 | 2022-03-16 | Checkmate Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR TUMOR IMMUNOTHERAPY |
| EP3775218A1 (en) | 2018-04-09 | 2021-02-17 | Checkmate Pharmaceuticals | Packaging oligonucleotides into virus-like particles |
| MX2021002745A (es) * | 2018-09-11 | 2021-05-12 | Amgen Inc | Metodos de purificacion de oligonucleotidos ricos en guanina. |
| BR112021007527A2 (pt) * | 2018-10-30 | 2021-08-03 | Toray Industries, Inc. | inibidor de ligação não específica para ácido nucleico, reagente de hibridização para ácido nucleico, métodos de hibridização de ácido nucleico e de detecção de um ácido nucleico e uso de um ácido nucleico |
| WO2020093322A1 (zh) * | 2018-11-08 | 2020-05-14 | 深圳华大生命科学研究院 | 一种微流控芯片及其制备方法和dna合成方法 |
| US12202848B2 (en) * | 2019-10-18 | 2025-01-21 | Fujifilm Wako Pure Chemical Corporation | Phosphoramidite activator |
| US20230322842A1 (en) * | 2020-04-14 | 2023-10-12 | Sumitomo Chemical Company, Limited | Composition containing nucleic acid oligomer |
| CN114425443B (zh) * | 2020-10-29 | 2025-10-31 | 江苏金斯瑞生物科技有限公司 | 一种寡核苷酸合成催化剂 |
| GB202114688D0 (en) | 2021-10-14 | 2021-12-01 | Exactmer Ltd | Solution phase polymer synthesis |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60500817A (ja) * | 1983-06-01 | 1985-05-30 | ベツクマン・インストルメンツ・インコ−ポレ−テツド | ヌクレオシド・ホスホルアミダイト中間体の製造方法 |
| US20030050263A1 (en) | 1994-07-15 | 2003-03-13 | The University Of Iowa Research Foundation | Methods and products for treating HIV infection |
| ATE292980T1 (de) | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
| AU7350798A (en) | 1997-04-29 | 1998-11-24 | Universiteit Utrecht | Corona virus-like particles as tools for vaccination and therapy |
| AU750702B2 (en) | 1997-05-01 | 2002-07-25 | Chiron Corporation | Use of virus-like particles as adjuvants |
| US6171591B1 (en) | 1997-12-08 | 2001-01-09 | Pentamer Pharmaceuticals, Inc. | Recombinant nodavirus compositions and methods |
| US6541438B1 (en) | 1998-05-01 | 2003-04-01 | The Procter & Gamble Company | Laundry detergent and/or fabric care compositions comprising a modified cellulase |
| AU770802B2 (en) | 1998-10-21 | 2004-03-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Virus-like particles for the induction of autoantibodies |
| ES2317711T3 (es) | 1998-11-30 | 2009-04-16 | Cytos Biotechnology Ag | Presentacion molecular de alergenos, metodos de preparacion y uso. |
| JP2003520568A (ja) | 1999-02-02 | 2003-07-08 | バイオカシェ ファーマシューティカルズ， インコーポレイテッド | 高度な抗原提示プラットフォーム |
| JP2002537102A (ja) | 1999-02-26 | 2002-11-05 | カイロン コーポレイション | 吸着された高分子および微粒子を有するミクロエマルジョン |
| UA77152C2 (en) | 1999-09-25 | 2006-11-15 | Method for stimulation of immune response using nucleic acid-containing immunostimulating compositions, method for treatment of cancer and method for treatment or prophylaxis of allergy or asthma | |
| JP2003510290A (ja) | 1999-09-27 | 2003-03-18 | コーリー ファーマシューティカル グループ，インコーポレイテッド | 免疫刺激核酸誘導インターフェロンに関する方法 |
| US6949520B1 (en) | 1999-09-27 | 2005-09-27 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
| JP2003511420A (ja) | 1999-10-13 | 2003-03-25 | カイロン コーポレイション | タンパク質から細胞性免疫応答を得る方法 |
| AU1928201A (en) | 1999-11-24 | 2001-06-04 | Chiron Corporation | Hbv/hcv virus-like particle |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| WO2001062275A1 (en) | 2000-02-24 | 2001-08-30 | The Board Of Trustees Of The Leland Stanford Junior University | Adjuvant treatment by in vivo activation of dendritic cells |
| AU2002248185A1 (en) | 2000-12-14 | 2002-07-16 | Coley Pharmaceutical Group, Inc. | Inhibition of angiogenesis by nucleic acids |
| US20030050268A1 (en) | 2001-03-29 | 2003-03-13 | Krieg Arthur M. | Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases |
| EP1425040A2 (en) | 2001-09-14 | 2004-06-09 | Cytos Biotechnology AG | In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles |
| ATE447967T1 (de) | 2001-09-14 | 2009-11-15 | Cytos Biotechnology Ag | Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung |
| US7524950B2 (en) | 2001-10-31 | 2009-04-28 | Agilent Technologies, Inc. | Uses of cationic salts for polynucleotide synthesis |
| ATE489969T1 (de) | 2002-06-20 | 2010-12-15 | Cytos Biotechnology Ag | Verpackte virusartige partikel in kombination mit cpg zur verwendung als adjuvantien mit allergenen. herstellungsverfahren und verwendung |
| JP5022028B2 (ja) | 2003-03-26 | 2012-09-12 | サイトス・バイオテクノロジー・アクチェンゲゼルシャフト | メラン−ａペプチドアナログ−ウイルス様粒子コンジュゲート |
| US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
| US20060210588A1 (en) | 2003-03-26 | 2006-09-21 | Cytos Biotechnology Ag | Hiv-peptide-carrier-conjugates |
| CA2527102A1 (en) | 2003-07-10 | 2005-01-20 | Cytos Biotechnology Ag | Packaged virus-like particles |
| EP1646427A1 (en) * | 2003-07-22 | 2006-04-19 | Cytos Biotechnology AG | Cpg-packaged liposomes |
| JP4628686B2 (ja) * | 2004-02-25 | 2011-02-09 | 独立行政法人科学技術振興機構 | ホスホロアミダイトを含む３’末端ヌクレオシドユニット |
| EP1789460B1 (en) * | 2004-09-02 | 2013-01-09 | Isis Pharmaceuticals, Inc. | Polymeric beads for oligonucleotide synthesis |
| BRPI0516953A (pt) | 2004-09-21 | 2008-09-30 | Cytos Biotechnology Ag | partìculas do tipo vìrus compreendendo uma proteìna de fusão da proteìna de revestimento de ap205 e um polipeptìdeo antigênico |
| EP1973608A1 (en) | 2005-12-14 | 2008-10-01 | Cytos Biotechnology AG | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
-
2007
- 2007-12-12 CA CA2671873A patent/CA2671873C/en active Active
- 2007-12-12 JP JP2009541546A patent/JP5389662B2/ja active Active
- 2007-12-12 AU AU2007333147A patent/AU2007333147B2/en active Active
- 2007-12-12 WO PCT/US2007/087183 patent/WO2008073960A2/en not_active Ceased
- 2007-12-12 US US11/954,511 patent/US8586728B2/en active Active
- 2007-12-12 CN CN2007800498509A patent/CN101611048B/zh active Active
- 2007-12-12 EP EP07865549.5A patent/EP2125854B1/en active Active
-
2013
- 2013-10-15 US US14/054,068 patent/US20140200338A1/en not_active Abandoned
-
2015
- 2015-06-23 US US14/748,045 patent/US9914746B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512169A5 (enExample) | ||
| TW393513B (en) | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines | |
| US5594121A (en) | Enhanced triple-helix and double-helix formation with oligomers containing modified purines | |
| JP2022003044A5 (enExample) | ||
| JP2013523887A5 (enExample) | ||
| Lackey et al. | Acetal levulinyl ester (ALE) groups for 2′-hydroxyl protection of ribonucleosides in the synthesis of oligoribonucleotides on glass and microarrays | |
| EP1256589A2 (en) | Oligomers containing modified pyrimidines | |
| JP2005518803A5 (enExample) | ||
| JP2005524393A5 (enExample) | ||
| JP2005517452A5 (enExample) | ||
| JPWO2021055811A5 (enExample) | ||
| CN110831951A (zh) | 多重偶联和氧化方法 | |
| JP2006526394A5 (enExample) | ||
| JP6732744B2 (ja) | ルテニウム触媒作用によるアゾベンゾール類からのビフェニルアミン類の製造方法 | |
| CN101475505A (zh) | 甲灭酸的制备方法 | |
| CN110590886A (zh) | 修饰核苷、核苷酸和核酸聚合物及其制备方法与应用 | |
| CN115197289A (zh) | 用于测序的核苷酸类似物 | |
| WO2019021945A1 (ja) | 可視光域で光架橋可能な光応答性ヌクレオチドアナログ | |
| US20230148152A1 (en) | Method of synthesizing single-stranded nucleotide sequence, blocked nucleoside triphosphates and related methods | |
| JP2008545782A5 (enExample) | ||
| CN102351621A (zh) | 一种n-砜基脒的制备方法 | |
| JP7298866B2 (ja) | 核酸合成用固相担体及びそれを用いた核酸の製造方法 | |
| JP2009507478A5 (enExample) | ||
| KR20080051502A (ko) | 2-데옥시-엘-리보오스의 제조방법 | |
| Jessen et al. | Design of an Intercalating Linker Leading to the First Efficiently 5′, 5′‐Linked Alternate‐Strand Hoogsteen Triplex with High Stability and Specificity |